ConductScience.org, home

Paper20409751

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.

Songun I and 4 others. Lancet Oncol, 2010. Cited by 1,390 papers, by iCite.

Cite this record

ConductScience Library. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Papers, record 20409751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20409751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
PubMed
Journal
Lancet Oncol
PubMed
Year
2010
PubMed
Publication types
Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1,390
iCite
Relative citation ratio, by iCite
43
iCite
Revised in PubMed
2022-04-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Songun IIlfet
2Putter HHein
3Kranenbarg EMElma Meershoek-Klein
4Sasako MMitsuru
5van de Velde CJCornelis J H

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Lymph Node ExcisionMajor topic
Stomach NeoplasmsMajor topic
Aged
Female
Follow-Up Studies
Gastrectomy
Humans
Male
Prospective Studies
Survival Analysis

Source PubMed

Download CSV of topics

Trials6

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01476553Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric CancerBackgroundClinicalTrials.gov
NCT01609309Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01)BackgroundClinicalTrials.gov
NCT03229096Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric CancerBackgroundClinicalTrials.gov
NCT03680261Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. ChemoradiotherapyBackgroundClinicalTrials.gov
NCT04734821Fluorescence Image Guided Foregut SurgeryBackgroundClinicalTrials.gov
NCT06466902Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)BackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in20409753Extended follow-up after extended lymphadenectomy for gastric cancer: was it worth the wait?https://conductscience.org/library/papers/20409753

Source PubMed

Download CSV of comments and corrections

Cited by846

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,390 citations.

PMIDTitleJournalYearIn PapersSource
42970017[Minimally invasive and robotic gastrectomy].Chirurgie (Heidelb)2026https://conductscience.org/library/papers/42970017PubMed
42959646Gastric Cancer: Epidemiology, Risk Factors, Pathogenesis, Clinical Features, Diagnosis, and Management.MedComm (2020)2026https://conductscience.org/library/papers/42959646PubMed
42934447
Extent of Lymph Node Examination in Older Adults with Gastric Adenocarcinoma: Is There a Trade-off Between Survival and Short-Term Outcomes? : Benefit of Lymph Node Yield in Older Adults with Gastric Cancer.
Ann Surg Oncol2026https://conductscience.org/library/papers/42934447PubMed
42846330Re-evaluation of lymph node dissection and surgical strategy for locally advanced gastric cancer in the era of neoadjuvant immunotherapy: a narrative review.Front Oncol2026https://conductscience.org/library/papers/42846330PubMed
42820568Fluorescence-guided lymphadenectomy in gastric cancer surgery: a novel intraoperative indocyanine green injection.Arq Bras Cir Dig2026https://conductscience.org/library/papers/42820568PubMed
42809545Prognostic impact of postoperative complications among elderly patients with gastric cancer.PLoS One2026https://conductscience.org/library/papers/42809545PubMed
42807388Glycolytic Reprogramming Mediated by the OTUD4-FXR1-HIF1A Axis Drives Gastric Cancer Progression.Int J Biol Sci2026https://conductscience.org/library/papers/42807388PubMed
42742771Complexity and heterogeneity of vascular anatomy in gastric cancer surgery: a multicenter retrospective cohort study.J Robot Surg2026https://conductscience.org/library/papers/42742771PubMed
42690309Clinicopathological features, morbidity and survival in gastric adenocarcinoma, with a focus on stage III: a retrospective institutional cohort analysis.Arq Bras Cir Dig2026https://conductscience.org/library/papers/42690309PubMed
42682346Operative safety and oncologic outcomes of robotic and laparoscopic total gastrectomy for advanced middle-upper gastric cancer: a multicenter retrospective study.Int J Surg2026https://conductscience.org/library/papers/42682346PubMed
42665277Diagnostic performance of Node-RADS in assessing regional lymph node metastasis and prognosis in resected gastric cancer.Sci Prog2026https://conductscience.org/library/papers/42665277PubMed
42632878Impact of Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) on Survival Following Surgery for Esophagogastric Cancer: A Systematic Review and Meta-analysis.Ann Surg Oncol2026https://conductscience.org/library/papers/42632878PubMed
42514138Comparative Effectiveness of Adjuvant XELOX Versus TS-1 Monotherapy After D2 Gastrectomy for Stage III Gastric Cancer: A Real-World Nationwide Cohort Study.Life (Basel)2026https://conductscience.org/library/papers/42514138PubMed
42482917Mechanobiological and microenvironmental roles of lymph nodes in cancer: implications for lymph node de-escalation.Front Med (Lausanne)2026https://conductscience.org/library/papers/42482917PubMed
42448965Non-exposure LECS (CLEAN-NET) for gastric cancer: long-term outcomes of a function-preserving strategy with selective nodal assessment.Surg Endosc2026https://conductscience.org/library/papers/42448965PubMed
42352420Current Status and Challenges of Local Resection for Early Gastric Cancer in East Asia.Cancers (Basel)2026https://conductscience.org/library/papers/42352420PubMed
42077699Clinicopathological Characteristics and Survival Outcomes in Patients With Gastric Adenocarcinoma: A 16-Year Experience From a Single Tertiary Center in Tunisia.Cureus2026https://conductscience.org/library/papers/42077699PubMed
41999560Survival Impact of Adjuvant Chemotherapy on Stage IB Gastric Cancer Patients After Radical Surgery.J Gastrointest Cancer2026https://conductscience.org/library/papers/41999560PubMed
41959925Differences in patient-reported symptoms following radical gastrectomy: a propensity score-matched cohort study.Front Oncol2026https://conductscience.org/library/papers/41959925PubMed
41879959Limited lymphadenectomy for elderly patient with gastric cancer: a systematic review and meta-analysis.Gastric Cancer2026https://conductscience.org/library/papers/41879959PubMed

See all 846 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20409751

GET https://conductscience.org/api/papers/v1/20409751/cited_by?page=2